AptarGroup

39 articles about AptarGroup

• Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year

  3/20/2024

  AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, was named to the CDP Supplier Engagement Leaderboard, for the fourth consecutive year.

• Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details

  1/18/2024

  AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, declared a quarterly cash dividend of $0.41 per share.

• Aptar Announces 2024 Quarterly Conference Call Dates

  1/2/2024

  AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, announced the dates and times of quarterly conference calls for the year.

• Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers

  12/4/2023

  AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, is announcing a contract with the U.S. Food and Drug Administration to study the challenges with developing low Global Warming Potential propellant metered dose inhalers.

• Aptar Announces 2023 Investor Day

  8/24/2023

  AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Friday, September 8, 2023.

• Aptar Reports Second Quarter 2023 Results

  7/27/2023

  AptarGroup, Inc. reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems and significant sequential improvement in injectables sales as Enterprise Resource Planning system implementation effects moderated.

• Aptar Announces Quarterly Dividend Increase of 7.9%

  7/13/2023

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.41 per share, an almost 8% increase from the previous dividend amount, bringing the new annualized dividend to $1.64 per share.

• Aptar Mourns Passing of Ervin J. LeCoque, First CEO and Board Chairman as a Publicly Traded Company

  6/26/2023

  AptarGroup, Inc., announced with great sadness that Ervin “Erv” J. LeCoque, the first Chief Executive Officer and Chairman of the Board when Aptar became a publicly traded company, has passed away.

• Aptar Reports First Quarter 2023 Results

  4/27/2023

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, reported strong operational performance driven by Aptar’s Pharma and Beauty segments.

• Aptar Declares Quarterly Dividend - April 20, 2023

  4/20/2023

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

• Aptar Surpasses Emissions Reduction Goals and Issues Updated Science-Based Targets in Line with 1.5°C Climate Ambition

  3/15/2023

  AptarGroup, Inc. announced that it has updated its Scope 1 and 2 science-based targets, setting an emissions reduction goal consistent with requirements to limit global temperature rise to 1.5° Celsius by year 2030.

• Aptar to Present at 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023

  12/21/2022

  AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023.

• Aptar Declares Quarterly Dividend - October 13, 2022

  10/13/2022

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

• Aptar Reports Second Quarter 2022 Results

  7/28/2022

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, reported net income of $64 million for the quarter ended June 30, 2022, a 15% increase over the prior year.

• Aptar Declares Quarterly Dividend - Apr 14, 2022

  4/14/2022

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, declared a quarterly cash dividend of $0.38 per share.

• AptarGroup, Inc. Announces Pricing of $400 Million of 3.600% Senior Notes due 2032

  3/3/2022

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced the pricing of an underwritten public offering of $400 million aggregate principal amount of its 3.600% Senior Notes due 2032.

• Aptar Reports Fourth Quarter and Annual 2021 Results

  2/17/2022

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions and services, reported fourth quarter and annual results for 2021.

• Aptar Declares Quarterly Dividend and Announces 2022 Annual Meeting Details

  1/20/2022

  AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active material science solutions, declared a quarterly cash dividend of $0.38 per share.

• Aptar Announces 2022 Quarterly Conference Call Dates

  1/4/2022

  AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

• Aptar Declares Quarterly Dividend

  10/14/2021

  AptarGroup, Inc. today declared a quarterly cash dividend of $0.38 per share. The payment date is November 17, 2021, to stockholders of record as of October 27, 2021.